Upregulation of Protein Synthesis and Proteasome Degradation Confers Sensitivity to Proteasome Inhibitor Bortezomib in Myc-Atypical Teratoid/Rhabdoid Tumors.

Myc-ATRTs bortezomib p53 proteasome degradation protein synthesis

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
22 Mar 2020
Historique:
received: 16 01 2020
revised: 12 03 2020
accepted: 20 03 2020
entrez: 3 4 2020
pubmed: 3 4 2020
medline: 3 4 2020
Statut: epublish

Résumé

Atypical teratoid rhabdoid tumors (ATRTs) are among the most malignant brain tumors in early childhood and remain incurable. Myc-ATRT is driven by the

Identifiants

pubmed: 32235770
pii: cancers12030752
doi: 10.3390/cancers12030752
pmc: PMC7140067
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Ministry of Health and Welfare
ID : MOHW108-TDU-B-212-124010
Organisme : Ministry of Science and Technology
ID : MOST 108-2314-B-038-061-MY3
Organisme : Taipei Medical University Hospital
ID : 107TMU-TMUH-06
Organisme : Taipei Medical University Hospital
ID : 108TMU-TMUH-09

Références

Nucleic Acids Res. 2019 Jan 8;47(D1):D941-D947
pubmed: 30371878
Cancer Res. 2017 Nov 1;77(21):e31-e34
pubmed: 29092934
N Engl J Med. 2008 Aug 28;359(9):906-17
pubmed: 18753647
Oncogene. 2007 Mar 15;26(12):1681-92
pubmed: 16983338
Nat Commun. 2019 May 1;10(1):2014
pubmed: 31043611
Future Oncol. 2014 Aug;10(10):1795-807
pubmed: 25303058
Cell. 2017 Jul 27;170(3):564-576.e16
pubmed: 28753430
Prog Mol Biol Transl Sci. 2012;109:75-112
pubmed: 22727420
Cancer Cell. 2016 Dec 12;30(6):891-908
pubmed: 27960086
Cancer Cell. 2019 Feb 11;35(2):204-220.e9
pubmed: 30753823
J Cell Mol Med. 2002 Jan-Mar;6(1):25-48
pubmed: 12003667
Nat Rev Clin Oncol. 2017 Jul;14(7):417-433
pubmed: 28117417
Cancer. 2012 Aug 1;118(15):3812-21
pubmed: 22180295
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Clin Cancer Res. 2003 Mar;9(3):1145-54
pubmed: 12631620
N Engl J Med. 2015 Mar 5;372(10):944-53
pubmed: 25738670
Int J Cancer. 2019 Apr 15;144(8):1983-1995
pubmed: 30230537
Nat Rev Cancer. 2010 Apr;10(4):301-9
pubmed: 20332779
EMBO J. 2007 May 2;26(9):2339-49
pubmed: 17431397
N Engl J Med. 2005 Jun 16;352(24):2487-98
pubmed: 15958804
Genome Biol. 2014;15(12):550
pubmed: 25516281
Nat Biotechnol. 2016 May;34(5):525-7
pubmed: 27043002
Cancer Res. 2001 Apr 1;61(7):3071-6
pubmed: 11306489
Cancer Res. 2003 Nov 1;63(21):7338-44
pubmed: 14612532
J Cell Biochem. 2015 Feb;116(2):218-24
pubmed: 25211508
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Clin Chem. 2000 May;46(5):673-83
pubmed: 10794750
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
Cancer Res. 2019 Jul 15;79(14):3595-3607
pubmed: 31138526
J Neurooncol. 2012 Apr;107(2):269-80
pubmed: 22120608
J Korean Neurosurg Soc. 2018 May;61(3):302-311
pubmed: 29742888
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
F1000Res. 2015 Dec 30;4:1521
pubmed: 26925227
Eur J Cancer. 2007 Jul;43(10):1581-9
pubmed: 17446062
Neuro Oncol. 2012 Feb;14(2):175-83
pubmed: 22156471
J Am Soc Nephrol. 2006 Jul;17(7):1807-19
pubmed: 16738015
Elife. 2019 Mar 12;8:
pubmed: 30860482
Int J Radiat Oncol Biol Phys. 2001 May 1;50(1):183-93
pubmed: 11316563
Neuro Oncol. 2018 Oct 1;20(suppl_4):iv1-iv86
pubmed: 30445539
Nat Commun. 2016 Jan 28;7:10421
pubmed: 26818002
Blood. 2006 Jun 15;107(12):4907-16
pubmed: 16507771
Cancer Res. 2009 Dec 1;69(23):8839-43
pubmed: 19934336
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Nat Methods. 2005 May;2(5):357-62
pubmed: 15846363
J Clin Endocrinol Metab. 2006 Oct;91(10):4013-21
pubmed: 16849420
Neurogenetics. 2006 May;7(2):67-80
pubmed: 16572319
Pediatr Blood Cancer. 2013 Jul;60(7):1095-102
pubmed: 23382118
Carcinogenesis. 2014 Oct;35(10):2164-74
pubmed: 24832085
J Leukoc Biol. 2012 Nov;92(5):921-31
pubmed: 22685320
Neuro Oncol. 2015 Jan;16 Suppl 10:x1-x36
pubmed: 25542864
Blood. 2007 Jun 1;109(11):4936-43
pubmed: 17284530
Cancer Cell. 2016 Mar 14;29(3):379-393
pubmed: 26923874
Neuro Oncol. 2011 Dec;13(12):1296-307
pubmed: 21946044
Clin Cancer Res. 2001 May;7(5):1419-28
pubmed: 11350913
Blood. 2003 Feb 15;101(4):1530-4
pubmed: 12393500
Sci Rep. 2016 Sep 23;6:34019
pubmed: 27659694

Auteurs

Huy Minh Tran (HM)

International Master/Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.
Department of Neurosurgery, Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City 700000, Vietnam.

Kuo-Sheng Wu (KS)

Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.

Shian-Ying Sung (SY)

The Ph.D. Program for Translational Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei 110, Taiwan.

Chun Austin Changou (CA)

The Ph.D. Program for Translational Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei 110, Taiwan.
The Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology and Academia Sinica, Taipei Medical University, Taipei 110, Taiwan.

Tsung-Han Hsieh (TH)

Joint Biobank, Office of Human Research, Taipei Medical University, Taipei 110, Taiwan.

Yun-Ru Liu (YR)

Joint Biobank, Office of Human Research, Taipei Medical University, Taipei 110, Taiwan.

Yen-Lin Liu (YL)

Department of Pediatrics, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.
Department of Pediatrics, Taipei Medical University Hospital, Taipei 110, Taiwan.
Pediatric Brain Tumor Program, Taipei Cancer Center, Taipei Medical University, Taipei 110, Taiwan.

Min-Lan Tsai (ML)

Department of Pediatrics, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.
Department of Pediatrics, Taipei Medical University Hospital, Taipei 110, Taiwan.
Pediatric Brain Tumor Program, Taipei Cancer Center, Taipei Medical University, Taipei 110, Taiwan.

Hsin-Lun Lee (HL)

Department of Radiation Oncology, Taipei Medical University Hospital, Taipei Medical University, Taipei 110, Taiwan.
Taipei Cancer Center, Taipei Medical University, Taipei 110, Taiwan.

Kevin Li-Chun Hsieh (KL)

Department of Medical Imaging, Taipei Medical University Hospital, Taipei 110, Taiwan.

Wen-Chang Huang (WC)

Department of Pathology, Wan Fang Hospital, Taipei Medical University, Taipei 110, Taiwan.

Muh-Lii Liang (ML)

Division of Pediatric Neurosurgery, Neurological Institute, Taipei Veterans General Hospital, Taipei 112, Taiwan.

Hsin-Hung Chen (HH)

Division of Pediatric Neurosurgery, Neurological Institute, Taipei Veterans General Hospital, Taipei 112, Taiwan.

Yi-Yen Lee (YY)

Division of Pediatric Neurosurgery, Neurological Institute, Taipei Veterans General Hospital, Taipei 112, Taiwan.

Shih-Chieh Lin (SC)

Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei 112, Taiwan.

Donald Ming-Tak Ho (DM)

Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei 112, Taiwan.
Department of Pathology and Laboratory Medicine, Cheng Hsin General Hospital, Taipei 112, Taiwan.

Feng-Chi Chang (FC)

Department of Radiology, Taipei Veterans General Hospital, Taipei 112, Taiwan.

Meng-En Chao (ME)

Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.

Wan Chen (W)

Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.

Shing-Shung Chu (SS)

Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.

Alice L Yu (AL)

Institute of Stem Cell and Translational Cancer Research, Chang Gung Memorial Hospital at Linkou and Chang Gung University, Taoyuan 333, Taiwan.
Genomics Research Center, Academia Sinica, Taipei 115, Taiwan.

Yun Yen (Y)

The Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology and Academia Sinica, Taipei Medical University, Taipei 110, Taiwan.
TMU Research Center of Cancer Translational Medicine, Taipei Medical University Taipei, Taipei 110, Taiwan.

Che-Chang Chang (CC)

The Ph.D. Program for Translational Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei 110, Taiwan.
Neuroscience Research Center, Taipei Medical University Hospital, Taipei 110, Taiwan.

Tai-Tong Wong (TT)

Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.
Pediatric Brain Tumor Program, Taipei Cancer Center, Taipei Medical University, Taipei 110, Taiwan.
Division of Pediatric Neurosurgery, Department of Neurosurgery, Taipei Medical University Hospital and Taipei Neuroscience Institute, Taipei Medical University, Taipei 110, Taiwan.
Neuroscience Research Center, Taipei Medical University Hospital, Taipei 110, Taiwan.

Classifications MeSH